Literature DB >> 12503787

Role of the chemokine eotaxin in the pathogenesis of equine sweet itch.

C Benarafa1, M E Collins, A S Hamblin, F M Cunningham.   

Abstract

The chemokine eotaxin is involved in the recruitment of eosinophils and T helper 2 lymphocytes in human allergic diseases, and drugs that block its activity, including eotaxin receptor (CCR3) antagonists, are being developed. The authors have recently cloned the horse ortholog of eotaxin and shown that it can induce equine eosinophil migration and activation in vitro. Moreover, eotaxin mRNA expression was upregulated in cultured horse dermal fibroblasts exposed to equine interleukin-4, suggesting a possible source of this eosinophil chemoattractant in equine skin. The results of this study show that eotaxin and monocyte chemoattractant protein (MCP) 1, but not MCP-2 or MCP-4, mRNA expression is upregulated in skin biopsies of sweet itch lesions when eosinophils are present, when compared with clinically normal skin from the same ponies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12503787

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  3 in total

1.  Eosinophils increase neuron branching in human and murine skin and in vitro.

Authors:  Erin L Foster; Eric L Simpson; Lorna J Fredrikson; James J Lee; Nancy A Lee; Allison D Fryer; David B Jacoby
Journal:  PLoS One       Date:  2011-07-21       Impact factor: 3.240

2.  Active vaccination against interleukin-5 as long-term treatment for insect-bite hypersensitivity in horses.

Authors:  Antonia Fettelschoss-Gabriel; Victoria Fettelschoss; Florian Olomski; Katharina Birkmann; Franziska Thoms; Maya Bühler; Martin Kummer; Andris Zeltins; Thomas M Kündig; Martin F Bachmann
Journal:  Allergy       Date:  2018-11-25       Impact factor: 13.146

3.  Interleukin 31 in insect bite hypersensitivity-Alleviating clinical symptoms by active vaccination against itch.

Authors:  Florian Olomski; Victoria Fettelschoss; Sigridur Jonsdottir; Katharina Birkmann; Franziska Thoms; Eliane Marti; Martin F Bachmann; Thomas M Kündig; Antonia Fettelschoss-Gabriel
Journal:  Allergy       Date:  2020-02-06       Impact factor: 13.146

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.